Segment information (Tables)

9 Months Ended

Sep. 25, 2016

The following tables present the Company’s segment results for the three and nine months ended September 25, 2016 and September 27, 2015:



	Three Months Ended				Nine Months Ended
	September 25, 2016		September 27, 2015		September 25, 2016		September 27, 2015
	(Dollars in thousands)				(Dollars in thousands)
Revenue
Vascular North America	$	85,118	$	82,675	$	254,817	$	244,606
Anesthesia North America	48,670		47,628		143,821		138,656
Surgical North America	41,827		39,591		123,904		118,170
EMEA	121,398		120,854		375,198		379,268
Asia	64,087		61,935		176,434		172,506
OEM	41,418		38,959		115,693		111,592
All other	53,130		52,072		164,227		160,391
Consolidated net revenues	$	455,648	$	443,714	$	1,354,094	$	1,325,189



	Three Months Ended						Nine Months Ended
	September 25, 2016			September 27, 2015			September 25, 2016			September 27, 2015
	(Dollars in thousands)						(Dollars in thousands)
Operating profit
Vascular North America	$	21,781		$	18,086		$	63,431		$	50,891
Anesthesia North America	13,954			15,178			41,181			36,572
Surgical North America	14,050			12,814			39,654			39,456
EMEA	16,576			19,656			61,563			65,334
Asia	18,072			15,715			52,831			42,812
OEM	10,201			8,865			24,605			25,274
All other	3,444			5,551			16,623			15,499
Total segment operating profit (1)	98,078			95,865			299,888			275,838
Unallocated expenses (2)	(11,591		)	(19,315		)	(47,463		)	(56,694		)
Income from continuing operations before interest, loss on extinguishment of debt and taxes	$	86,487		$	76,550		$	252,425		$	219,144

(1)

Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.


(2)	Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.